Literature DB >> 15506928

Transcriptional regulation by the Wilms' tumour suppressor protein WT1.

K J Wagner1, S G E Roberts.   

Abstract

Wilms' tumour is a paediatric malignancy of the kidneys and is the most common solid tumour found in children. The Wilms' tumour suppressor protein WT1 is mutated in approximately 15% of Wilms' tumours, and is aberrantly expressed in many others. WT1 can manifest both tumour suppressor and oncogenic activities, but the reasons for this are not yet clear. The Wilms' tumour suppressor protein WT1 is a transcriptional activator, the function of which is under cell-context-specific control. We have previously described a small region at the N-terminus of WT1 (suppression domain) that inhibits the transcriptional activation domain by contacting a co-suppressor protein. We recently identified BASP1 as one of the components of the co-suppressor. Here, we analyse the mechanism of action of the WT1 suppression domain, and discuss its function in the context of the role of WT1 as a regulator of development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15506928     DOI: 10.1042/BST0320932

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  7 in total

1.  BASP1 and its N-end fragments (BNEMFs) dynamics in rat brain during development.

Authors:  Ekaterina Kropotova; Boris Klementiev; Mark Mosevitsky
Journal:  Neurochem Res       Date:  2013-04-12       Impact factor: 3.996

2.  Characterization of a human TSPY promoter.

Authors:  Britta Skawran; Stephanie Schubert; Frank Dechend; Jörg Vervoorts; Karim Nayernia; Bernhard Lüscher; Jörg Schmidtke
Journal:  Mol Cell Biochem       Date:  2005-08       Impact factor: 3.396

3.  BASP1 promotes apoptosis in diabetic nephropathy.

Authors:  Maria Dolores Sanchez-Niño; Ana Belen Sanz; Corina Lorz; Andrea Gnirke; Maria Pia Rastaldi; Viji Nair; Jesus Egido; Marta Ruiz-Ortega; Matthias Kretzler; Alberto Ortiz
Journal:  J Am Soc Nephrol       Date:  2010-01-28       Impact factor: 10.121

4.  Wilms' tumor 1 silencing decreases the viability and chemoresistance of glioblastoma cells in vitro: a potential role for IGF-1R de-repression.

Authors:  Mike Y Chen; Aaron J Clark; Dana C Chan; Joy L Ware; Shawn E Holt; Archana Chidambaram; Helen L Fillmore; William C Broaddus
Journal:  J Neurooncol       Date:  2010-09-04       Impact factor: 4.130

5.  Inhibition of Myc-induced cell transformation by brain acid-soluble protein 1 (BASP1).

Authors:  Markus Hartl; Andrea Nist; M Imran Khan; Taras Valovka; Klaus Bister
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-18       Impact factor: 11.205

Review 6.  Mechanisms of transcriptional regulation by WT1 (Wilms' tumour 1).

Authors:  Eneda Toska; Stefan G E Roberts
Journal:  Biochem J       Date:  2014-07-01       Impact factor: 3.857

7.  ¹H, ¹³C and ¹⁵N resonance assignments of human BASP1.

Authors:  Leonhard Geist; Anna Zawadzka-Kazimierczuk; Saurabh Saxena; Szymon Żerko; Wiktor Koźmiński; Robert Konrat
Journal:  Biomol NMR Assign       Date:  2012-11-20       Impact factor: 0.746

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.